326 related articles for article (PubMed ID: 15019942)
21. Remyelination in the CNS: from biology to therapy.
Franklin RJ; Ffrench-Constant C
Nat Rev Neurosci; 2008 Nov; 9(11):839-55. PubMed ID: 18931697
[TBL] [Abstract][Full Text] [Related]
22. Retinoid X receptor gamma signaling accelerates CNS remyelination.
Huang JK; Jarjour AA; Nait Oumesmar B; Kerninon C; Williams A; Krezel W; Kagechika H; Bauer J; Zhao C; Baron-Van Evercooren A; Chambon P; Ffrench-Constant C; Franklin RJM
Nat Neurosci; 2011 Jan; 14(1):45-53. PubMed ID: 21131950
[TBL] [Abstract][Full Text] [Related]
23. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.
Arnett HA; Fancy SP; Alberta JA; Zhao C; Plant SR; Kaing S; Raine CS; Rowitch DH; Franklin RJ; Stiles CD
Science; 2004 Dec; 306(5704):2111-5. PubMed ID: 15604411
[TBL] [Abstract][Full Text] [Related]
24. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.
Kotter MR; Li WW; Zhao C; Franklin RJ
J Neurosci; 2006 Jan; 26(1):328-32. PubMed ID: 16399703
[TBL] [Abstract][Full Text] [Related]
25. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
Kriks S; Shim JW; Piao J; Ganat YM; Wakeman DR; Xie Z; Carrillo-Reid L; Auyeung G; Antonacci C; Buch A; Yang L; Beal MF; Surmeier DJ; Kordower JH; Tabar V; Studer L
Nature; 2011 Nov; 480(7378):547-51. PubMed ID: 22056989
[TBL] [Abstract][Full Text] [Related]
26. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency.
Shen S; Sandoval J; Swiss VA; Li J; Dupree J; Franklin RJ; Casaccia-Bonnefil P
Nat Neurosci; 2008 Sep; 11(9):1024-34. PubMed ID: 19160500
[TBL] [Abstract][Full Text] [Related]
27. Extensive remyelination of the CNS leads to functional recovery.
Duncan ID; Brower A; Kondo Y; Curlee JF; Schultz RD
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6832-6. PubMed ID: 19342494
[TBL] [Abstract][Full Text] [Related]
28. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage.
Pohl HB; Porcheri C; Mueggler T; Bachmann LC; Martino G; Riethmacher D; Franklin RJ; Rudin M; Suter U
J Neurosci; 2011 Jan; 31(3):1069-80. PubMed ID: 21248132
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
Kirik D; Cederfjäll E; Halliday G; Petersén Å
Neurobiol Dis; 2017 Jan; 97(Pt B):179-188. PubMed ID: 27616425
[TBL] [Abstract][Full Text] [Related]
30. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Warren Olanow C; Bartus RT; Baumann TL; Factor S; Boulis N; Stacy M; Turner DA; Marks W; Larson P; Starr PA; Jankovic J; Simpson R; Watts R; Guthrie B; Poston K; Henderson JM; Stern M; Baltuch G; Goetz CG; Herzog C; Kordower JH; Alterman R; Lozano AM; Lang AE
Ann Neurol; 2015 Aug; 78(2):248-57. PubMed ID: 26061140
[TBL] [Abstract][Full Text] [Related]
31. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Palfi S; Gurruchaga JM; Ralph GS; Lepetit H; Lavisse S; Buttery PC; Watts C; Miskin J; Kelleher M; Deeley S; Iwamuro H; Lefaucheur JP; Thiriez C; Fenelon G; Lucas C; Brugières P; Gabriel I; Abhay K; Drouot X; Tani N; Kas A; Ghaleh B; Le Corvoisier P; Dolphin P; Breen DP; Mason S; Guzman NV; Mazarakis ND; Radcliffe PA; Harrop R; Kingsman SM; Rascol O; Naylor S; Barker RA; Hantraye P; Remy P; Cesaro P; Mitrophanous KA
Lancet; 2014 Mar; 383(9923):1138-46. PubMed ID: 24412048
[TBL] [Abstract][Full Text] [Related]
32. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.
Barker RA; Barrett J; Mason SL; Björklund A
Lancet Neurol; 2013 Jan; 12(1):84-91. PubMed ID: 23237903
[TBL] [Abstract][Full Text] [Related]
33. Mutant huntingtin is present in neuronal grafts in Huntington disease patients.
Cicchetti F; Lacroix S; Cisbani G; Vallières N; Saint-Pierre M; St-Amour I; Tolouei R; Skepper JN; Hauser RA; Mantovani D; Barker RA; Freeman TB
Ann Neurol; 2014 Jul; 76(1):31-42. PubMed ID: 24798518
[TBL] [Abstract][Full Text] [Related]
34. The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence.
Cisbani G; Cicchetti F
Neuropathol Appl Neurobiol; 2014 Feb; 40(1):71-90. PubMed ID: 24304236
[TBL] [Abstract][Full Text] [Related]
35. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Lang AE; Gill S; Patel NK; Lozano A; Nutt JG; Penn R; Brooks DJ; Hotton G; Moro E; Heywood P; Brodsky MA; Burchiel K; Kelly P; Dalvi A; Scott B; Stacy M; Turner D; Wooten VG; Elias WJ; Laws ER; Dhawan V; Stoessl AJ; Matcham J; Coffey RJ; Traub M
Ann Neurol; 2006 Mar; 59(3):459-66. PubMed ID: 16429411
[TBL] [Abstract][Full Text] [Related]
36. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.
Barker RA; Parmar M; Studer L; Takahashi J
Cell Stem Cell; 2017 Nov; 21(5):569-573. PubMed ID: 29100010
[TBL] [Abstract][Full Text] [Related]
37. Generating human neurons in vitro and using them to understand neuropsychiatric disease.
Paşca SP; Panagiotakos G; Dolmetsch RE
Annu Rev Neurosci; 2014; 37():479-501. PubMed ID: 25002278
[TBL] [Abstract][Full Text] [Related]
38. Neuronal repair. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke.
Wahl AS; Omlor W; Rubio JC; Chen JL; Zheng H; Schröter A; Gullo M; Weinmann O; Kobayashi K; Helmchen F; Ommer B; Schwab ME
Science; 2014 Jun; 344(6189):1250-5. PubMed ID: 24926013
[TBL] [Abstract][Full Text] [Related]
39. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
Marks WJ; Bartus RT; Siffert J; Davis CS; Lozano A; Boulis N; Vitek J; Stacy M; Turner D; Verhagen L; Bakay R; Watts R; Guthrie B; Jankovic J; Simpson R; Tagliati M; Alterman R; Stern M; Baltuch G; Starr PA; Larson PS; Ostrem JL; Nutt J; Kieburtz K; Kordower JH; Olanow CW
Lancet Neurol; 2010 Dec; 9(12):1164-1172. PubMed ID: 20970382
[TBL] [Abstract][Full Text] [Related]
40. Division and differentiation of isolated CNS blast cells in microculture.
Temple S
Nature; 1989 Aug; 340(6233):471-3. PubMed ID: 2755510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
